Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Regeneron cocktail reduces viral loads in hospitalized patients with COVID-19 Ken Downey Jr.
• ‘A global wake-up call’: In shadow of COVID-19, TB deaths rise for first time in 15 years Caitlyn Stulpin
• Among people with HIV, Black women have highest rate of premature death Ken Downey Jr.
• Amount of toxin in stool correlates with C. difficile severity, study shows Caitlyn Stulpin
• Antibiotic prescribing in pediatric practices declined 73% amid pandemic Stephanie C. Viguers
• AstraZeneca’s mAb cocktail reduces risk for symptomatic COVID-19 Caitlyn Stulpin
• C. difficile prevalent in non-health care settings — especially on shoes Caitlyn Stulpin
• CDC advisory committee updates recommendations for pneumococcal, zoster vaccines Ken Downey Jr.
• Cell-based flu vaccine effective among children in randomized trial Rose Weldon
• COVID-19 ‘joins a long list’ of conditions that disproportionately impact minority groups Caitlyn Stulpin
• CYPRESS trial: RSV vaccine effective in older adults John C. Schoen, MA
• FDA authorizes Pfizer’s pediatric COVID-19 vaccine for emergency use Rose Weldon
• FDA expands approval of Biktarvy to include younger children with HIV Rose Weldon
• FDA says newly authorized COVID-19 test could double capacity for rapid at-home testing
• Global routine vaccination coverage fell in 2020 Ken Downey Jr.
• Health officials allow Americans to choose their own booster shot Ken Downey Jr.
• ‘Historic moment’: WHO recommends malaria vaccine for children Caitlyn Stulpin
• HIV PrEP awareness low among cisgender women, especially women of color Caitlyn Stulpin
• HIV self-testing program widely accepted by people who use drugs Caitlyn Stulpin
• Interferon adds no clinical benefit for hospitalized patients with COVID-19 Ken Downey Jr.
• Medicare plans limit access to treatments for C. difficile infection Caitlyn Stulpin
• Microbiota-based CDI treatment successful and safe, studies show Caitlyn Stulpin
• More than half of COVID-19 survivors experience symptoms 6 months after recovery Ken Downey Jr.
• Neutralizing antibodies remain 6 months after SARS-CoV-2 infection in kids Rose Weldon
• Nirsevimab effective against RSV in late preterm, term infants Rose Weldon
• ‘No unexpected patterns of adverse reactions’ among thousands who received third shot Ken Downey Jr.
• Oteseconazole proves safe, effective against recurrent vulvovaginal candidiasis Richard Gawel
• Pediatric COVID-19 cases spike in areas without school mask mandates Rose Weldon
• People with HIV do not respond as well to COVID-19 vaccines, study finds Ken Downey Jr.
• Rapid HCV treatment model increases cure rates in young people who inject drugs Maria Marabito
• Saliva could be used to predict COVID-19 severity in kids, early analysis finds Rose Weldon
• Single-dose lysin shows promise against S. aureus in phase 2 trial Ken Downey Jr.
• Social media ‘has the capacity to revolutionize medicine’ Caitlyn Stulpin
• Stewardship program reduces ambulatory antibiotic prescriptions Caitlyn Stulpin
• Study evaluates T-cell testing for Lyme disease Ken Downey Jr.
• Survey: Many Americans likely to continue pandemic precautions through flu season Caitlyn Stulpin
• Unlike flu, cold viruses persisted during pandemic, study finds Gerard Gallagher; Rose Weldon
• ‘We just have to keep pushing’: Universal flu vaccine remains out of reach, for now Caitlyn Stulpin
• Beta-lactams before vancomycin reduces mortality from bloodstream infections Caitlyn Stulpin
• Long-acting ART safe, effective at 124 weeks Caitlyn Stulpin
• If you could eliminate influenza or coronaviruses, which would you choose?
• Hooked on ID with Melanie A. Thompson, MD
• Most racial, ethnic groups underrepresented in pediatric clinical trials Maria Marabito
• Mycoplasma genitalium: A formidable foe in need of new treatment, diagnostic options Jeff Brock, PharmD, MBA, BCIDP